Endo Vitd No Screening Obesity

---
name: endo-vitd-no-screening-obesity
description: This skill recommends against routine 25-hydroxyvitamin D [25(OH)D] screening and subsequent vitamin D supplementation in adults with obesity when no established indication exists. It is triggered by clinician questions such as “Should I screen for vitamin D deficiency in this obese patient?” or “Is vitamin D testing indicated based on BMI?”
---

# Against routine vitamin D screening in obese adults

## STEP 1 — Gather Information
Collect BMI to confirm obesity (BMI ≥30 kg/m²) and assess for established indications for 25(OH)D testing (e.g., hypocalcemia, malabsorption syndromes, chronic kidney disease, medications affecting vitamin D metabolism, osteoporosis, history of fractures, or falls).

## STEP 2 — Rule In / Rule Out
If an established indication for 25(OH)D testing is present, proceed to evaluate per that indication; if no established indication exists, classify as obesity without indication and move to recommend against screening.

## STEP 3 — Classify or Stratify
Classify the patient as either “obesity with established indication for vitamin D testing” or “obesity without established indication for vitamin D testing” based on the presence of the conditions gathered in Step 1.

## STEP 4 — Decide
For patients classified as obesity without established indication, advise against routine 25(OH)D screening and empiric vitamin D supplementation; ensure adequate calcium intake and safe sun exposure to meet Dietary Reference Intakes, and consider lifestyle measures for weight management.

## Clinical Guardrails / Mimics / Pitfalls
Do not screen or treat based solely on BMI; avoid ordering 25(OH)D tests incidentally in asymptomatic obese patients; do not initiate high‑dose intermittent vitamin D regimens for obesity alone; recognize that musculoskeletal pain or fatigue in obesity may have other causes and should not prompt vitamin D testing without additional clinical clues.

## Concrete Clinical Example
A 52‑year‑old woman with BMI 34 kg/m² presents for routine follow‑up, denies bone pain, muscle weakness, or known malabsorption, and asks whether she should have her vitamin D level checked. The clinician advises against routine 25(OH)D screening, recommends adequate calcium and safe sun exposure per DRI, and notes that vitamin D supplementation is not indicated for obesity alone.

**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290